Multivitamin Solution for Injection

البلد: أيرلندا

اللغة: الإنجليزية

المصدر: HPRA (Health Products Regulatory Authority)

العنصر النشط:

Vitamin A palmitate ; Vitamin D3 ; Vitamin E acetate ; Thiamine hydrochloride ; Riboflavin sodium phosphate ; Pyridoxine Hydrochloride; Nicotinamide; Dexpanthenol; Cyanocobalamin

متاح من:

Norbrook Laboratories (Ireland) Limited

ATC رمز:

QA11E

INN (الاسم الدولي):

Vitamin A palmitate ; Vitamin D3 ; Vitamin E acetate ; Thiamine hydrochloride ; Riboflavin sodium phosphate ; Pyridoxine Hydrochloride; Nicotinamide; Dexpanthenol; Cyanocobalamin

جرعة:

.

الشكل الصيدلاني:

Solution for injection

نوع الوصفة الطبية :

LM: Licensed Merchant as defined in relevant national legislation

المجال العلاجي:

VITAMIN B-COMPLEX, INCL. COMBINATIONS

الوضع إذن:

Authorised

تاريخ الترخيص:

1991-10-01

خصائص المنتج

Health Products Regulatory Authority
07 February 2019
CRN008TGN
Page 1 of 5
SUMMARY OF PRODUCT CHARACTERISTICS
1 NAME OF THE VETERINARY MEDICINAL PRODUCT
Multivitamin Solution for Injection
2 QUALITATIVE AND QUANTITATIVE COMPOSITION
ACTIVE SUBSTANCES:
QUANTITY PER ML:
Vitamin A Palmitate
15,000I.U
Cholecalciferol (Vitamin D3)
25micrograms
Vitamin E Acetate
20mg
Thiamine Hydrochloride (Vitamin B1)
10mg
Riboflavin Sodium Phosphate (Vitamin B2)
5mg
Pyridoxine Hydrochloride (Vitamin B6)
3mg
Nicotinamide
35mg
Dexpanthenol
25mg
Cyanocobalamin (Vitamin B12)
25micrograms
EXCIPIENTS:
Chlorocresol (preservative)
1.0mg
Butylated hydroxyanisole (antioxidant)
0.1mg
Butylated hydroxytoluene (antioxidant)
0.1mg
For a full list of excipients, see Section 6.1.
3 PHARMACEUTICAL FORM
Solution for injection
A gold coloured sterile aqueous solution.
4 CLINICAL PARTICULARS
4.1 TARGET SPECIES
Cattle, Pigs, Sheep
4.2 INDICATIONS FOR USE, SPECIFYING THE TARGET SPECIES
For the prevention and treatment of vitamin deficiencies in animals,
particularly
during periods of illness, convalescence and general unthriftiness.
Health Products Regulatory Authority
07 February 2019
CRN008TGN
Page 2 of 5
4.3 CONTRAINDICATIONS
Do not use in animals known to be hypersensitive to the active
substances.
4.4 SPECIAL WARNINGS FOR EACH TARGET SPECIES
None.
4.5 SPECIAL PRECAUTIONS FOR USE
SPECIAL PRECAUTIONS FOR USE IN ANIMALS:
None
SPECIAL PRECAUTIONS TO BE TAKEN BY THE PERSON ADMINISTERING THE
PRODUCT TO
ANIMALS:
None known.
4.6 ADVERSE REACTIONS (FREQUENCY AND SERIOUSNESS)
In very rare cases (i.e. less than 1 animal in 10,000 animals)
allergic type reactions
may occur, and in extreme cases these can result in death.
4.7 USE DURING PREGNANCY, LACTATION OR LAY
Multivitamin Injection can be safely administered to pregnant and
lactating animals.
4.8 INTERACTION WITH OTHER MEDICINAL PRODUCTS AND OTHER FORMS OF
INTERACTIONS
None known.
4.9 AMOUNTS TO BE ADMINISTERED AND ADMINISTRATION ROUTE
Administer by intramuscular or subcutaneous injection. Avoid the
introduc